# The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis

> **NCT03141112** · — · UNKNOWN · sponsor: **Radovan Uvizl** · enrollment: 200 (estimated)

## Conditions studied

- Severe Sepsis

## Interventions

- **PROCEDURE:** renal replacement therapy

## Key facts

- **NCT ID:** NCT03141112
- **Lead sponsor:** Radovan Uvizl
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-12
- **Final completion:** 2020-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03141112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03141112, "The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03141112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*